- Conditions
- Alzheimer's Disease (AD)
- Interventions
- Oxaloacetate (OAA) 1g, Oxaloacetate (OAA) 2g
- Drug
- Lead sponsor
- Russell Swerdlow
- Other
- Eligibility
- 50 Years to 85 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–4
of 4
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Alzheimer's Disease
- Interventions
- S -Equol, Placebo
- Drug
- Lead sponsor
- Russell Swerdlow, MD
- Other
- Eligibility
- 60 Years to 90 Years · Female only
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
- Conditions
- Alzheimer's Disease
- Interventions
- Oxaloacetate (OAA)
- Dietary Supplement
- Lead sponsor
- Russell Swerdlow, MD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
- Conditions
- Alzheimer Disease
- Interventions
- S-equol and Placebo, Placebo and S-equol
- Drug
- Lead sponsor
- Russell Swerdlow
- Other
- Eligibility
- 50 Years to 90 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 2
- States / cities
- Fairway, Kansas • Kansas City, Kansas